U.S. Cannabis Market Size, Share & Trends Analysis Report By End-use (Medical, Recreational, Industrial), By Source (Marijuana, Hemp), By Derivative (CBD, THC),- Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033

Chapter 1 Research Methodology and Scope

1.1 Research Process

1.2 Information Procurement

1.2.1 Purchased database:

1.2.1.1 internal database

1.2.2 Market Formulation & Validation

1.3 Research Methodology

1.4 Research Scope and Assumptions

1.5 List to Data Sources

Chapter 2 Executive Summary

2.1 Market Outlook

2.2 Segment Outlook

2.3 Competitive Insights

2.4 The U.S. Cannabis Market Snapshot

Chapter 3 U.S. Cannabis Market Variables, Trends & Scope

3.1 Market Segmentation

3.2 Penetration and Growth Prospect Mapping

3.3 The U.S. Cannabis Market Dynamics

3.3.1 Market Driver Analysis

3.3.2 Market Restraints Analysis

3.3.4 Opportunity Analysis (2016-2021-2030)

3.3.5 The U.S. Cannabis Industry Case Study

3.3.5.1 Legalization of Cannabis:

3.3.5.2 Reason for Legalization:

3.3.5.3 Scenario After Legalization and Consumer Attitudes:

3.3.5.4 Competitive Landscape Post Legalization:

3.3.6 The U.S. Cannabis Regulatory Scenario

3.3.7 The U.S. Cannabis Market - PESTLE Analysis

3.3.8 Industry Analysis - Porter’s

Chapter 4 U.S. Cannabis Market: End-Use Estimates & Trend Analysis

4.1 Cannabis Market: End-Use Movement Analysis

4.2 Medical

4.2.1 Medical market estimates and forecasts, 2021 - 2033

4.2.2 Cancer

4.2.2.1 Cancer Market Estimates And Forecasts, 2021 - 2033

4.2.3. Chronic Pain

4.2.3.1 Chronic Pain Market Estimates And Forecasts, 2021 - 2033

4.2.4 Depression And Anxiety

4.2.4.1 Depression And Anxiety Market Estimates And Forecasts, 2021 - 2033

4.2.5 Arthritis

4.2.5.1 Arthritis Market Estimates And Forecasts, 2021 - 2033

4.2.6 Diabetes

4.2.6.1 Diabetes Market Estimates And Forecasts, 2021 - 2033

4.2.7 Glaucoma

4.2.7.1 Glaucoma Market Estimates And Forecasts, 2021 - 2033

4.2.8 Migraines

4.2.8.1 Migraines Market Estimates And Forecasts, 2021 - 2033

4.2.9 Epilepsy

4.2.9.1 Epilepsy Market Estimates And Forecasts, 2021 - 2033

4.2.10 Multiple Sclerosis

4.2.10.1 Multiple Sclerosis Market Estimates And Forecasts, 2021 - 2033

4.2.11 AIDS

4.2.11.1 AIDS Market Estimates And Forecasts, 2021 - 2033

4.2.12 Amyotrophic Lateral Sclerosis

4.2.12.1 Amyotrophic Lateral Sclerosis Market Estimates And Forecasts, 2021 - 2033

4.2.13 Alzheimer's

4.2.13.1 Alzheimer's Market Estimates And Forecasts, 2021 - 2033

4.2.14 Post Traumatic Stress Disorder (Ptsd)

4.2.14.1 Post Traumatic Stress Disorder (Ptsd) Market Estimates And Forecasts, 2021 - 2033

4.2.15 Parkinson's

4.2.15.1 Parkinson's Market Estimates And Forecasts, 2021 - 2033

4.2.16 Tourette’s

4.2.16.1 Tourette’s Market Estimates And Forecasts, 2021 - 2033

4.2.17 Others

4.2.17.1 Others Market Estimates And Forecasts, 2021 - 2033

4.3 Recreational

4.3.1 Recreational market estimates and forecasts, 2021 - 2033

4.4 Industrial

4.4.1 Industrial market estimates and forecasts, 2021 - 2033

Chapter 5 U.S. Cannabis Market: Source Type Estimates & Trend Analysis

5.1 U.S. Cannabis Market: Source Type Movement Analysis

5.2 Marijuana

5.2.1 Marijuana market estimates and forecasts, 2021 - 2033

5.2.2 Flowers

5.2.2.1 Flowers Market Estimates And Forecasts, 2021 - 2033

5.2.3 Oil And Tinctures

5.2.3.1 Oil And Tinctures Market Estimates And Forecasts, 2021 - 2033

5.3 Hemp

5.3.1 Hemp market estimates and forecasts, 2021 - 2033

5.3.2 Hemp CBD

5.3.2.1 Hemp CBD Market Estimates And Forecasts, 2021 - 2033

5.3.3 Supplements

5.3.3.1 Supplements Market Estimates And Forecasts, 2021 - 2033

5.3.4. Industrial Hemp

5.3.4..1 Industrial Hemp Market Estimates And Forecasts, 2021 - 2033

Chapter 6 U.S. Cannabis Market: Derivative Estimates & Trend Analysis

6.1 U.S. Cannabis Market: Derivative Movement Analysis

6.2 CBD

6.2.1 CBD market estimates and forecasts, 2021 - 2033

6.3 THC

6.3.1 CBD market estimates and forecasts, 2021 - 2033

6.4 Others

6.4.1 Other market estimates and forecasts, 2021 - 2033

Chapter 7 Competitive Landscape

7.1 Company Profiles

7.1.1 CANOPY GROWTH CORPORATION

7.1.1.1 Funding

7.1.1.2 Number of Employees

7.1.1.3 Headquarters

7.1.1.4 Business Model (Product Offerings)

7.1.1.5 Growers, Manufacturers, Retailers

7.1.1.6 Revenue 2020(USD Mn)

7.1.1.7 Net Loss 2020 (USD Mn

7.1.1.8 Valuation (USD Mn)

7.1.1.9 Regions With Commercial Presence

7.1.2 GW PHARMACEUTICALS, PLC

7.1.2.1 Funding

7.1.2.2 Number of Employees

7.1.2.3 Headquarters

7.1.2.4 Business Model (Product Offerings)

7.1.2.5 Growers, Manufacturers, Retailers

7.1.2.6 Revenue 2020(USD Mn)

7.1.2.7 Net Loss 2020 (USD Mn

7.1.2.8 Valuation (USD Mn)

7.1.2.9 Regions With Commercial Presence

7.1.3 AURORA CANNABIS, INC.

7.1.3.1 Funding

7.1.3.2 Number of Employees

7.1.3.3 Headquarters

7.1.3.4 Business Model (Product Offerings)

7.1.3.5 Growers, Manufacturers, Retailers

7.1.3.6 Revenue 2020(USD Mn)

7.1.3.7 Net Loss 2020 (USD Mn

7.1.3.8 Valuation (USD Mn)

7.1.3.9 Regions With Commercial Presence

7.1.4 APHRIA, INC. (PRIOR TO MERGER WITH TILRAY)

7.1.4.1 Funding

7.1.4.2 Headquarters

7.1.4.3 Business Model (Product Offerings)

7.1.4.4 Growers, Manufacturers, Retailers

7.1.4.5 Valuation (USD Mn)

7.1.4.6 Regions With Commercial Presence

7.1.5 CRONOS GROUP

7.1.5.1 Funding

7.1.5.2 Number of Employees

7.1.5.3 Headquarters

7.1.5.4 Business Model (Product Offerings)

7.1.5.5 Growers, Manufacturers, Retailers

7.1.5.6 Revenue 2020(USD Mn)

7.1.5.7 Net Loss 2020 (USD Mn

7.1.5.8 Valuation (USD Mn)

7.1.5.9 Regions With Commercial Presence

7.1.6 TILRAY

7.1.6.1 Funding

7.1.6.2 Number of Employees

7.1.6.3 Headquarters

7.1.6.4 Business Model (Product Offerings)

7.1.6.5 Growers, Manufacturers, Retailers

7.1.6.6 Revenue 2020(USD Mn)

7.1.6.7 Net Loss 2020 (USD Mn

7.1.6.8 Valuation (USD Mn)

7.1.6.9 Regions With Commercial Presence